Page last updated: 2024-10-24

mature B cell apoptotic process

Definition

Target type: biologicalprocess

Any apoptotic process in a B cell that is mature, having left the bone marrow. [CL:0000785, GOC:add, GOC:mtg_apoptosis, ISBN:0781735149]

Mature B cell apoptosis is a tightly regulated process essential for maintaining immune homeostasis and preventing autoimmunity. It involves a cascade of molecular events leading to programmed cell death. The process can be triggered by various stimuli, including antigen receptor engagement in the absence of co-stimulation, exposure to toxins, and growth factor withdrawal.

**Key Steps in Mature B Cell Apoptosis:**

1. **Initiation:** Upon receiving an apoptotic signal, B cells activate intracellular signaling pathways. These pathways can involve death receptors like Fas (CD95) or TNF receptor, as well as intrinsic pathways triggered by mitochondrial dysfunction.
2. **Caspase Activation:** Activation of initiator caspases (caspase-8 and -9) marks the crucial point of no return. Caspase-8 is activated by the death receptor pathway, while caspase-9 is activated by the mitochondrial pathway. These initiator caspases then activate executioner caspases (caspase-3, -6, and -7).
3. **Execution Phase:** Activated executioner caspases initiate the dismantling of the cell. They cleave key proteins involved in cell structure, DNA repair, and protein synthesis. This leads to the characteristic features of apoptosis, such as DNA fragmentation, nuclear condensation, and cell shrinkage.
4. **Apoptotic Body Formation:** The apoptotic cell breaks down into membrane-enclosed fragments called apoptotic bodies. These bodies contain the cellular debris and are readily phagocytosed by neighboring cells or macrophages, preventing inflammation and immune system activation.

**Regulation of Mature B Cell Apoptosis:**

B cell apoptosis is tightly regulated to ensure appropriate responses to various stimuli. This regulation involves several key factors:

* **Survival Signals:** B cells receive survival signals from antigen receptors and co-stimulatory molecules, which activate signaling pathways promoting cell survival.
* **Apoptotic Inhibitors:** Anti-apoptotic proteins like Bcl-2 and Bcl-xL prevent mitochondrial dysfunction and caspase activation.
* **Apoptotic Inducers:** Pro-apoptotic proteins like Bax and Bak promote mitochondrial permeabilization and caspase activation.

**Consequences of Mature B Cell Apoptosis:**

* **Immune Homeostasis:** Apoptosis removes self-reactive B cells, preventing autoimmune diseases.
* **Negative Selection:** During B cell development, apoptosis eliminates immature B cells that recognize self-antigens.
* **Immune Tolerance:** Deletion of B cells that recognize foreign antigens without appropriate co-stimulation helps maintain immune tolerance.

**Dysregulation of Mature B Cell Apoptosis:**

Dysregulation of B cell apoptosis can lead to various pathologies, including:

* **Autoimmune Diseases:** Failure to eliminate self-reactive B cells can lead to autoimmune diseases like rheumatoid arthritis and lupus.
* **Cancer:** Defects in apoptotic pathways can contribute to B cell lymphoma development.

Mature B cell apoptosis is a fundamental process for maintaining immune system health and preventing disease.'
"

Proteins (1)

ProteinDefinitionTaxonomy
Adenosine deaminaseAn adenosine deaminase that is encoded in the genome of human. [PRO:DNx, UniProtKB:P00813]Homo sapiens (human)

Compounds (10)

CompoundDefinitionClassesRoles
9-(2-hydroxy-3-nonyl)adenine9-(2-hydroxy-3-nonyl)adenine: specific inhibitor of adenosine deaminase
coformycincoformycinsEC 3.5.4.4 (adenosine deaminase) inhibitor
adenosinequinquefolan B: isolated from roots of Panax quinquefolium L.; RN not in Chemline 10/87; RN from Toxlitadenosines;
purines D-ribonucleoside
analgesic;
anti-arrhythmia drug;
fundamental metabolite;
human metabolite;
vasodilator agent
nebularinenebularine : A purine ribonucleoside that is 9H-purine attached to a beta-D-ribofuranosyl residue at position 9 via a glycosidic (N-glycosyl) linkage.

nebularine: structure
purine ribonucleoside;
purines D-ribonucleoside
fungal metabolite
9-(2-hydroxy-3-nonyl)adenine(2R,3S)-EHNA : EHNA of absolute configuration 2R,3S. Selective inhibitor of cGMP-stimulated phosphodiesterase (PDE2) (IC50 = 0.8 - 4 mM). Also a potent inhibitor of adenosine deaminase.EHNAEC 3.1.4.* (phosphoric diester hydrolase) inhibitor;
EC 3.5.4.4 (adenosine deaminase) inhibitor
9-(2-hydroxy-3-nonyl)adenine(2S,3R)-EHNA : EHNA of absolute configuration 2S,3R.EHNA
1-deazaadenosine1-deazaadenosine: inhibits nucleic acid & protein synthesis; structure given in first source
pentostatinpentostatin : A member of the class of coformycins that is coformycin in which the hydroxy group at position 2' is replaced with a hydrogen. It is a drug used for the treatment of hairy cell leukaemia.

Pentostatin: A potent inhibitor of ADENOSINE DEAMINASE. The drug induces APOPTOSIS of LYMPHOCYTES, and is used in the treatment of many lymphoproliferative malignancies, particularly HAIRY CELL LEUKEMIA. It is also synergistic with some other antineoplastic agents and has immunosuppressive activity.
coformycinsantimetabolite;
antineoplastic agent;
Aspergillus metabolite;
bacterial metabolite;
EC 3.5.4.4 (adenosine deaminase) inhibitor
8-azanebularine8-azanebularine: structure in first source
msh, 4-nle-7-phe-alpha-polypeptidedermatologic drug